Use of azithromycin is beneficial only as primary prophylaxis. Comparison of azithromycin leukocyte disposition in. A large trail comparing rifabutin 300 mg daily, a currently approved primary prophylactic agent for mac, with azithromycin 1200 mg weekly has been completed and is under analysis. Once weekly azithromycin therapy for prevention of. Patients undergoing treatment with a macrolide regimen who demonstrate microbiologic and clinical relapse harbor macrolideresistant organisms. The results of our study confirm azithromycin s long intracellular halflife and slow release from white blood cells. Azithromycin azithromycin dose, indications, adverse.
Prophylaxis against disseminated mycobacterium avium. Acquired immune deficiency syndrome aids is the most advanced stage of infection with human immunodeficiency virus hiv. Prophylaxis should be continued for the patients lifetime unless multiple drug therapy for mac becomes necessary because of the development of mac disease. Recommended for patients with cd4 count less than 200 cellsmm3 or cd4 less than 15%. Background azithromycin is active in treating mycobacterium avium complex disease, but it has not been evaluated as primary prophylaxis in patients with human immunodeficiency virus hiv infection. Mononuclear and polymorphonuclear leukocyte dispositions. Azithromycin 600 mg po twice weekly biii rifabutin dose adjusted based on concomitant art a bi. After mixing, store the suspension at 41f to 86f 5c to 30c.
Mortality risk after aids defining opportunistic illness among hivinfected personssan francisco, 19812012. Once weekly azithromycin therapy for prevention of mycobacterium avium complex infection in patients with aids. Patients with a tendency to develop gastrointestinal side effects e. Weekly azithromycin has been shown to be an effective and convenient agent for primary prophylaxis against disseminated mac in hivpositive patients, although its use as a secondary prophylaxis has. Azithromycin, azalide with high and prolonged intracellular levels, promise to provide to protection against mycobacterium avium complex mac disease in those with advanced aids when given weekly. In studies published in the early 1990s, the incidence of disseminated mac ranged from 20 to 40 percent in patients with advanced immunosuppression not receiving mac prophylaxis. The typical dosage is 30 mgkg of body weight taken as a single dose, or 10 mgkg of body weight once per day for 3 days. Prophylaxis to prevent first episode of opportunistic disease page 3 of 7 opportunistic infections indication preferred alternative histoplasmosis cd4 count. In studies published in the early 1990s, the incidence of disseminated mac ranged from 20 to 40 percent in patients with advanced immunosuppression not receiving mac prophylaxis 5,6. The most common clinical manifestations of mac include recurrent fever, night sweats, weight loss and anaemia. Azithromycin as prophylaxis for m avium complex disease provides additional protection against p carinii over and above that of standard pcp prophylaxis. Azithromycin as treatment for disseminated mycobacterium.
The recommended regimen is rifabutin, 300 mg by mouth daily, for the patients lifetime. Usual adult dose for bacterial endocarditis prophylaxis. The spectrum of disease is predominately limited to pulmonary manifestations and lymphadenitis in normal hosts and disseminated disease in severely immunocompromised hosts, namely aids. Mycobacterium avium complex mac includes the organisms mycobacterium avium and mycobacterium intracellulare and are ubiquitous in the environment. People who have a cd4 cell count of less than 50 may develop mac. Store azithromycin dry powder for oral suspension below 86f 30c in a tightly closed container. Toxoplasmosis is the most common central nervous system infection in patients with the acquired immunodeficiency syndrome aids who are not receiving appropriate prophylaxis. Some clinicians would add rifabutin as a third drug ci. They are used in the treatment of a variety of infections, including communityacquired respiratory tract infections and mycobacterial infections. The incidence of mycobacterium avium complex mac in persons with hiv has decreased with the widespread use of potent antiretroviral therapy art. Choosing wisely in hiv medicine should we stop giving. Tables 2 and 3 below summarize the antibiotics used for primary and secondary prophylaxis of opportunistic infections and their appropriate dosages. 150 cellsl and at high risk because of occupational. Clarithromycin plus ethambutol is superior to azithromycin plus ethambutol in sterilizing the blood in disseminated mac.
One opportunistic infection in people with hiv is mac. The aids clinical trials group 196terry beirn community programs for clinical research on aids. Usual adult dose for mycobacterium aviumintracellulare prophylaxis. Clarithromycin is the most active mac antimicrobial agent and should be part of any drug regimen for treating active mac disease in patients with or without aids. Azithromycin and clarithromycin are derivatives of the older macrolide antibiotic erythromycin. In a comparative study n 296, this dosing regimen for azithromycin. Disseminated infection with mycobacterium avium complex mac is an important opportunistic infection in hivpositive individuals. Mycobacterium avium complex mac is composed of two species, m. Recommended for those who are not on fully suppressive art, after ruling out active disseminated mac disease ai. Diagnosis, therapy, and prophylaxis for hivinfected children follow similar guidelines. Discontinuation of prophylaxis against mycobacterium avium. Guidelines for preventing opportunistic infections among. Mepron atovaquone dose, indications, adverse effects. Mycobacterium avium complex mac is an opportunistic pathogen which resides in and replicates intracellularly in leukocytes, and as a result, disease due to this organism presents therapeutic challenges 8, 9, 15.
Initial treatment of mac disease should consist of two or more antimycobacterial drugs to prevent or delay the emergence of resistance ai. Is primary mycobacterium avium complex prophylaxis. Prophylaxis with clarithromycin, azithromycin, or rifabutin is highly effective in preventing dmac in atrisk aids patients ie, those with an absolute cd4 count of prophylaxis. The incidence of mac increases as the cd4 cell count drops below 50.
Clarithromycin is more active in vitro and has been more extensively studied than azithromycin. Patients with disseminated mac disease should continue chronic maintenance therapy secondary prophylaxis unless immune reconstitution occurs due to art. Episodes of nonmac bacterial infection per 100 patient years occurred in 43 azithromycin recipients and 88 placebo recipients relative risk, 0. These data support the onceweekly dosing of azithromycin for mac prophylaxis and confirm that aids. Azithromycin 3 day dose pack is used to treat many different types of infections caused by bacteria, including infections of the lungs, sinus, throat, tonsils, skin, urinary tract, cervix, or genitals azithromycin 3 day dose. Store azithromycin tablets between 59f and 86f 15c to 30c. The most common toxic effect noted during the study was gastrointestinal, reported by 78. Azithromycin 600 mg po twice weekly biii rifabutin dose adjusted. However, owing to their extensive penetration of infected cells 5, 11, 14, 17, both clarithromycin clr and azithromycin. Primary prophylaxis with azithromycin may be more effective at reducing the incidence of mac at 30 days in people with aids. Baseline characteristics of patients with aids and cd4 yields a 50% power to detect a reduction of the infection rate cell counts of l100mm3 who received azithromycin or placebo as mycobacterium avium. If disseminated mac develops, a treatment regimen containing clarithromycin or azithromycin and at least one other agent is recommended.
Mycobacterium avium complex mac infections in persons with hiv. Do not use azithromycin if the original seal over the container opening is broken or missing. Treatment of mac disease with clarithromycin in a dose of 1,000 mg twiceday is associated with a higher mortality rate than has been observed with clarithromycin administered at 500 mg twiceday. Mac isolates should be tested for susceptibility to this drug in all patients.
Safety and efficacy for prophylaxis of mac infection in children have not been established. Testing mac isolates for susceptibility to clarithromycin or azithromycin is recommended for all people with hiv. Mycobacterium avium complex mac azithromycin compared with placebo. Once weekly azithromycin as prophylaxis against recurrence. Is prophylaxis for mycobacterium avium complex mac, with either clarithromycin, azithromycin, or rifabutin, indicated in children with hiv infection who have advanced immunosuppression to prevent mac infection prophylaxis with either clarithromycin or azithromycin. Panels recommendations for mycobacterium avium complex disease. Although both azithromycin and clarithromycin are well tolerated by children, azithromycin. Prophylaxis to prevent first episode of opportunistic disease page 3 of 7. Finally, high oral azithromycin doses have been given to aids patients for treatment of disseminated mycobacterium avium complex mac. Prophylaxis and therapy for disseminated mycobacterium. Efficacy of azithromycin in prevention of pneumocystis. Macrolidecontaining regimens are the standard of care for treatment of disseminated mycobacterium avium complex mac. The doctor may also prescribe 10 mgkg of body weight on day 1.
The recommended dose is 500 mg po on first day of therapy, followed by 250 mg po once daily for 4 days. A randomized, doubleblind, placebocontrolled trial. Azithromycin dose to maximize efficacy and suppress. Although detecting mac organisms in the respiratory or gastrointestinal tract might predict disseminated mac infection, no data are available regarding efficacy of prophylaxis with clarithromycin, azithromycin. The azithromycin exposures to be achieved by the different doses were a plasma steadystate auc 024 mic of 3. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of mycobacterium avium complex disease in patients with aids.
1345 1296 1302 1320 628 112 816 708 1498 213 901 1147 480 159 58 778 618 560 1428 884 643 363 247 1083 1233 859 903 189 229 442 262 392 783 463 831 338 422